MANUEL SILVA CARMONA to Treatment Outcome
This is a "connection" page, showing publications MANUEL SILVA CARMONA has written about Treatment Outcome.
Connection Strength
0.072
-
Response to Eculizumab in Escherichia coli O157: H7-induced hemolytic uremic syndrome with severe neurological manifestations. Clin Pediatr (Phila). 2015 Apr; 54(4):387-9.
Score: 0.035
-
Novel SAMD9 Variant Causing MIRAGE Syndrome Treated with Subcutaneous Immunoglobulin. J Clin Immunol. 2024 09 30; 45(1):19.
Score: 0.018
-
The Pathology of Pulmonary Disease After Pediatric Hematopoietic Stem Cell Transplantation. Am J Surg Pathol. 2024 Oct 01; 48(10):1201-1214.
Score: 0.018